DGx DGX クエスト・ダイアグノスティックス

 DGXのチャート


 DGXの企業情報

symbol DGx
会社名 Quest Diagnostics Inc. (DGX クエスト・ダイアグノスティックス)
分野(sector)   
産業(industry)   
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 事業概要 クエスト・ダイアグノスティクス(Quest Diagnostics Incorporated)は診断情報サービスのプロバイダである。同社は診断情報サービスと診断ソリューションという2つの事業を通じて事業を行う。診断情報サービス事業は患者、臨床医、病院、統合送達ネットワーク(IDN)、医療計画、雇用主、アカウンタブルケア組織(ACO)を含む顧客向けインサイトを提供する診断テスト情報とサービスを開発する 。診断ソリューション事業には保険会社向けのソリューションを提供するリスクアセスメントサービス事業と、医療提供者向けのソリューションを提供する医療情報技術ビジネスが含まれる。同社のサービスは「Quest Diagnostics」ブランドで提供され、「AmeriPath」、「Dermpath Diagnostics」、「Focus Diagnostics」、「Athena Diagnostics」、「ExamOne」、「Quanum」、「Care360」などの他のブランドのサービスも提供する。  クエスト・ダイアグノスティクスは米国の医療検査サ―ビス企業。医療診断検査や医療情報、関連サ―ビスを提供。血液・尿・微生物検査や生体組織・細胞検査、遺伝子検査、臨床試験を行うほか、診断検査キットを製造・販売する。検査結果閲覧システム「Care360」、カルテ管理システム「ChartMaxx」、その他医療関連ソフトウェアを提供。本社はニュ―ジャ―ジ―州。  Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
本社所在地 973 520-2700
代表者氏名 Stephen H. Rusckowski
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 973-520-2700
設立年月日 1967年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 46000人
url www.QuestDiagnostics.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 1536.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 12072.82000
売上高 売上高(百万ドル) 7531.00000
企業価値(EV) 企業価値(EV)(百万ドル) 15830.82000
当期純利益 当期純利益(百万ドル) 719.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Quest Diagnostics Inc revenues increased 2% to $7.53B. Net income applicable to common stockholders excluding extraordinary items increased 8% to $719M. Revenues reflect DIS Business segment increase of 2% to $7.2B. Net income benefited from General corporate activities segment loss decrease of 10% to $181M. Dividend per share increased from $1.80 to $1.95.

 DGXのテクニカル分析


 DGXのニュース

   Quest Diagnostics Stock Is Believed To Be Fairly Valued  2021/06/25 00:00:10 GuruFocus
Related Stocks: DGX ,
   Direct-to-Consumer Laboratory Testing Market New Study Offers Insights for 2027 Covid-19 Analysis | Konica Minolta, Any Lab Test Now, Quest Diagnostics  2021/06/24 08:54:43 OpenPR
The Global Direct-to-Consumer Laboratory Testing market examines existing trends, dynamics, and perspectives, as well as forecasting the market''s current state and possible prospects over the forecast period of 2021 to 2027. The report offers in-depth insights into market dynamics to
   Global Clinical Laboratory Services Market to 2025 - Featuring Exact Sciences, Quest Diagnostics and Sonic Healthcare Among Others - ResearchAndMarkets.com  2021/06/22 16:29:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Clinical Laboratory Services Market, 6th Edition" report has been added to ResearchAndMarkets.com''s offering. This report provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies. Information is presented as a global focused market report, with key regions discussed inclu
   Quest Diagnostics Releases Annual Corporate Responsibility Report  2021/06/21 10:45:00 PR Newswire
SECAUCUS, N.J., June 21, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world''s leading provider of diagnostic information services, today released the Annual Corporate Responsibility Report for 2020. Titled "A Year of Challenge and Change," the report features the
   Specimen Validity Testing Products Market With Leading Players like Thermo Fisher Scientific, Sciteck, American Bio Medica Corporation (ABMC), Express Diagnostics, Premier Biotech., LabCorp, Quest Diagnostics, Alere Toxicology, ACM Global Laboratories, Cl  2021/06/18 06:47:14 OpenPR
An off-the-shelf report on Specimen Validity Testing Products Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market
   The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings  2021/05/11 11:54:30 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV ) - Its Allergan subsidiary announced a deal to buy Soliton, Inc. (NASDAQ: SOLY ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Novo Nordisk A/S (NYSE: NVO ) Quest Diagnostics Incorporated (NYSE: DGX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 10) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 4D pharma plc (NASDAQ: LBPS ) Accelerate Diagnostics, Inc. (NASDAQ: AXDX ) Acutus Medical, Inc. (NASDAQ: AFIB ) Adagene Inc. (NASDAQ: ADAG ) Adaptive Biotechnologies Corporation (NASDAQ: ADPT ) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Aquestive Therapeutics, Inc. (NASDAQ: AQST ) Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) Athersys, Inc. (NASDAQ: ATHX ) Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH ) (reacted to publication of positive results for a late-stage asset in lupus nephritis) Autolus Therapeutics plc (NASDAQ: AUTL ) AVROBIO, Inc.
   The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data  2021/05/04 12:10:20 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV ) BioNTech SE – ADR (NASDAQ: BNTX ) (moving on momentum imparted by vaccine news flow) GT Biopharma Inc (NASDAQ: GTBP ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Lantheus Holdings Inc (NASDAQ: LNTH ) Orthopediatrics Corp (NASDAQ: KIDS ) Quest Diagnostics Incorporated (NYSE: DGX ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 3) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Aptinyx Inc. (NASDAQ: APTX ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AVROBIO, Inc. (NASDAQ: AVRO ) (reacted to the need for conducting a registrational trial for its gene therapy candidate for Fabry disease) Aziyo Biologics, Inc. (NASDAQ: AZYO ) Celyad Oncology SA (NASDAQ: CYAD ) Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) Cyclerion Therapeutics, Inc. (NASDAQ: CYCN ) Decibel Therapeutics, Inc.
   Quest Diagnostics quarterly profit surges 374%  2021/04/22 11:00:08 Investing.com
https://www.investing.com/news/stock-market-news/quest-diagnostics-quarterly-profit-surges-374-2482024
   Ex-Dividend Date Insight: Quest Diagnostics  2021/04/05 10:16:00 Benzinga
Quest Diagnostics (NYSE:DGX) declared a dividend payable on April 21, 2021 to its shareholders as of February 4, 2021. It was also announced that …
   Quest Diagnostics Offloads Interest in Q2 Solutions JV To IQVIA  2021/04/01 13:12:25 Benzinga
Quest Diagnostics Inc (NYSE: DGX ) has announced selling the minority share in Q2 Solutions to IQVIA Holdings Inc (NYSE: IQV ) for $760 million in cash. Q2 Solutions provides comprehensive testing, project … Full story available on Benzinga.com
   The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings  2021/05/11 11:54:30 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV ) - Its Allergan subsidiary announced a deal to buy Soliton, Inc. (NASDAQ: SOLY ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Novo Nordisk A/S (NYSE: NVO ) Quest Diagnostics Incorporated (NYSE: DGX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 10) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 4D pharma plc (NASDAQ: LBPS ) Accelerate Diagnostics, Inc. (NASDAQ: AXDX ) Acutus Medical, Inc. (NASDAQ: AFIB ) Adagene Inc. (NASDAQ: ADAG ) Adaptive Biotechnologies Corporation (NASDAQ: ADPT ) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Aquestive Therapeutics, Inc. (NASDAQ: AQST ) Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) Athersys, Inc. (NASDAQ: ATHX ) Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH ) (reacted to publication of positive results for a late-stage asset in lupus nephritis) Autolus Therapeutics plc (NASDAQ: AUTL ) AVROBIO, Inc.
   The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data  2021/05/04 12:10:20 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV ) BioNTech SE – ADR (NASDAQ: BNTX ) (moving on momentum imparted by vaccine news flow) GT Biopharma Inc (NASDAQ: GTBP ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Lantheus Holdings Inc (NASDAQ: LNTH ) Orthopediatrics Corp (NASDAQ: KIDS ) Quest Diagnostics Incorporated (NYSE: DGX ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 3) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Aptinyx Inc. (NASDAQ: APTX ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AVROBIO, Inc. (NASDAQ: AVRO ) (reacted to the need for conducting a registrational trial for its gene therapy candidate for Fabry disease) Aziyo Biologics, Inc. (NASDAQ: AZYO ) Celyad Oncology SA (NASDAQ: CYAD ) Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) Cyclerion Therapeutics, Inc. (NASDAQ: CYCN ) Decibel Therapeutics, Inc.
   Quest Diagnostics quarterly profit surges 374%  2021/04/22 11:00:08 Investing.com
https://www.investing.com/news/stock-market-news/quest-diagnostics-quarterly-profit-surges-374-2482024
   Ex-Dividend Date Insight: Quest Diagnostics  2021/04/05 10:16:00 Benzinga
Quest Diagnostics (NYSE:DGX) declared a dividend payable on April 21, 2021 to its shareholders as of February 4, 2021. It was also announced that …
   Quest Diagnostics Offloads Interest in Q2 Solutions JV To IQVIA  2021/04/01 13:12:25 Benzinga
Quest Diagnostics Inc (NYSE: DGX ) has announced selling the minority share in Q2 Solutions to IQVIA Holdings Inc (NYSE: IQV ) for $760 million in cash. Q2 Solutions provides comprehensive testing, project … Full story available on Benzinga.com

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 DGX クエスト・ダイアグノスティックス DGX )

 twitter  (公式ツイッターやCEOツイッターなど)